Moreover, upregulation of the drug-resistance gene annexin I (ANX-I) is associated with a poorer prognosis in NPC, breast cancer and gastric cancer25, and radio- and chemo-sensitivity could be induced by suppressing expression of Jab1/CSN526. Here, ANXA1 is linked to nasopharyngeal carcinoma.